Literature DB >> 14665710

Heparanase, galectin-3, and tissue factor mRNA are expressed in benign neoplasms of the thyroid.

Andreas E Buchs1, Sergei Zehavi, Osnat Sher, Eyal Yeheskely, Michael Muggia-Sulam, Yoav Sherman, Micha J Rapoport.   

Abstract

OBJECTIVE: Heparanase, galectin-3, and tissue factor (TF) are overexpressed in solid malignant thyroid tumors. We studied their expression in multinodular goiters (MNGs). DESIGN AND METHODS: Thyroid tissue specimens from 15 MNGs were obtained during surgery. mRNA expression for galectin-3, heparanase, and TF was assessed by RT-PCR.
RESULTS: Isolated expressions of heparanase and galectin- 3 mRNA were expressed in 2 and 4 of the 15 MNGs, respectively; 8/15 MNGs were positive for both heparanase and galectin-3. TF mRNA was found in all MNG specimens.
CONCLUSION: Galectin-3, heparanase, and TF RNA expression is prevalent in MNGs. Further studies will be needed to determine the prognostic significance of these findings.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14665710     DOI: 10.1385/ENDO:22:2:81

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.925


  19 in total

1.  Heparanase as mediator of angiogenesis: mode of action.

Authors:  M Elkin; N Ilan; R Ishai-Michaeli; Y Friedmann; O Papo; I Pecker; I Vlodavsky
Journal:  FASEB J       Date:  2001-07       Impact factor: 5.191

Review 2.  Intracellular functions of galectins.

Authors:  Fu-Tong Liu; Ronald J Patterson; John L Wang
Journal:  Biochim Biophys Acta       Date:  2002-09-19

3.  Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis.

Authors:  I Vlodavsky; Y Friedmann; M Elkin; H Aingorn; R Atzmon; R Ishai-Michaeli; M Bitan; O Pappo; T Peretz; I Michal; L Spector; I Pecker
Journal:  Nat Med       Date:  1999-07       Impact factor: 53.440

Review 4.  Mammalian heparanase as mediator of tumor metastasis and angiogenesis.

Authors:  I Vlodavsky; M Elkin; O Pappo; H Aingorn; R Atzmon; R Ishai-Michaeli; A Aviv; I Pecker; Y Friedmann
Journal:  Isr Med Assoc J       Date:  2000-07       Impact factor: 0.892

5.  Heparanase expression in clinical digestive malignancies.

Authors:  H Inoue; K Mimori; T Utsunomiya; N Sadanaga; G F Barnard; H Ueo; M Mori
Journal:  Oncol Rep       Date:  2001 May-Jun       Impact factor: 3.906

6.  Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules.

Authors:  A Gasbarri; M P Martegani; F Del Prete; T Lucante; P G Natali; A Bartolazzi
Journal:  J Clin Oncol       Date:  1999-11       Impact factor: 44.544

7.  Fast detection of tissue factor and tissue factor pathway inhibitor messenger RNA in endothelial cells and monocytes by sensitive reverse transcription-polymerase chain reaction.

Authors:  S Iochmann; P Reverdiau-Moalic; S Beaujean; E Rideau; Y Lebranchu; P Bardos; Y Gruel
Journal:  Thromb Res       Date:  1999-05-01       Impact factor: 3.944

Review 8.  Molecular properties and involvement of heparanase in cancer progression and normal development.

Authors:  I Vlodavsky; O Goldshmidt; E Zcharia; S Metzger; T Chajek-Shaul; R Atzmon; Z Guatta-Rangini; Y Friedmann
Journal:  Biochimie       Date:  2001-08       Impact factor: 4.079

9.  Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue.

Authors:  D Cvejic; S Savin; I Paunovic; S Tatic; M Havelka; J Sinadinovic
Journal:  Anticancer Res       Date:  1998 Jul-Aug       Impact factor: 2.480

10.  Galectin-3 is a presurgical marker of human thyroid carcinoma.

Authors:  F Orlandi; E Saggiorato; G Pivano; B Puligheddu; A Termine; S Cappia; P De Giuli; A Angeli
Journal:  Cancer Res       Date:  1998-07-15       Impact factor: 12.701

View more
  2 in total

1.  Global DNA methylation evaluation: potential complementary marker in differential diagnosis of thyroid neoplasia.

Authors:  Bogdan Galusca; Jean Marc Dumollard; Sandrine Lassandre; Alain Niveleau; Jean Michel Prades; Bruno Estour; Michel Peoc'h
Journal:  Virchows Arch       Date:  2005-05-13       Impact factor: 4.064

2.  The Profile of Heparanase Expression Distinguishes Differentiated Thyroid Carcinoma from Benign Neoplasms.

Authors:  Leandro Luongo Matos; Eloah Rabello Suarez; Thérèse Rachell Theodoro; Damila Cristina Trufelli; Carina Mucciolo Melo; Larissa Ferraz Garcia; Olivia Capela Grimaldi Oliveira; Maria Graciela Luongo Matos; Jossi Ledo Kanda; Helena Bonciani Nader; João Roberto Maciel Martins; Maria Aparecida Silva Pinhal
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.